baber/WOPTO huggingface dataset:
Patent NZ-581100-A (NZ)
Title: Garment with strap in perineal region such that anus is uncovered
Inventor: PHILLIPS CALBERT INGLIS
IPC: A41B9/02
Filed: 2009-11-11
Abstract: Female worn thong panties include a waistband 2, an anterior portion 4 to cover the vulva, and two strap portions 6 extending from a junction region 12 with the anterior portion that is located at the perennial region 10, either side of the anus 20, and up to join the waistband at 16. The wearer's anus 20 is left uncovered and material of the garment does not bridge between the anus and the vagina.
Patent NZ-587006-A (NZ)
Title: 11-cis-Retinal derivatives and methods for the use thereof for the treatment of visual disorders
Inventor: PALCZEWSKI KRZYSZTOF
IPC: C07C69/007
Filed: 2005-06-20
Abstract: Disclosed is the use of a retinal derivative as represented by the general formula (II) in the preparation of a medicament for use in the treatment of an endogenous 11-cis-retinal deficiency in the eye of a human subject; wherein A is CH2OR, CH(OH)OR, CH(ORa)ORb or CH=NOH and each R, Ra, and Rb is an aldehydic group, an alkane group, a carboxylate group, an alcohol group or a carboxylic acid. Also disclosed is a pharmaceutical composition which comprises i) a retinal derivative as defined above; and ii) a pharmaceutically acceptable vehicle, where the composition is formulated for oral administration or for ophthalmalogical administration. Of particular importance is the use of the retinal derivatives 11-cis-retinyl succinate, 11-cis-retinyl citrate, 11-cis-retinyl ketoglutarate, 11-cis-retinyl fumarate, 11-cis-retinyl malate or 11-cis-retinyl oxaloacetate.
Patent NZ-589327-A (NZ)
Title: Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
Inventor: ROCHE DIDIER
IPC: A61K31/343
Filed: 2009-03-30
Abstract: Disclosed are piperazine-benzofuran compounds. Examples of the claimed compounds include: 4-(4-Bromo-2-ethoxycarbonyl-benzofuran-5-yl)-p iperazine-1-carboxylic acid tert-butyl ester 4-(4-Bromo-2-carboxy-benzofuran-5-yl)-piperazine-1-carboxylic acid tert-butyl ester and 5-[4-(3-Methoxy-benzenesulfonyl)-piperazin-1-yl]-benzofuran-2-carboxylic acid amide. The compounds hypercholesterolemia, hyperlipoproteinemia, hypertriglyceridemia, dyslipidemia, lipodystrophy, cholestasislfibrosis, cholesterol gallstone disease, gastrointestinal disease or condition, hyperglycemia, diabetes mellitus, type 2 diabetes, insulin resistance, metabolic Inflexibility, nephropathy, liver diseases, atherosclerosis, cancer, inflammatory disorders, obesity, osteoporosis, skin aging, hair growth regulation and pigmentation disorders, Parkinson's disease and/or Alzheimer's disease.
Patent NZ-589731-A (NZ)
Title: Tidal turbine system with fixed blades that prevent axial loading from increasing above a predetermined threshold speed
Inventor: FREEMAN CHRISTOPHER
IPC: F03B13/26
Filed: 2009-06-19
Abstract: 589731 A tidal flow turbine system is disclosed comprising a rotor and a plurality of turbine blades at a fixed stagger angle with respect to the rotor. The blades are configured such that over a lower range of rotational and or tidal flow speeds increased speed results in increased axial loading on the turbine. However, at a higher speed range above a predetermined threshold axial loading on the turbine does not increase. The system reduces the thrust load on a seabed mounting structure without requiring any further braking arrangements.
Patent NZ-591115-A (NZ)
Title: Azaindazole compounds as ccr1 receptor antagonists
Inventor: COOK BRIAN NICHOLAS
IPC: A61K31/4375
Filed: 2009-09-22
Abstract: Disclosed is an azaindazole compound of formula (I) where the substituents are as disclosed in the specification. Examples of compounds of formula (I) are: 1-(4-Fluorophenyl)-1H-pyrazolo[3,4-c ]pyridine-4-carboxylic acid 3-trifluoromethyl-benzylamide; 1-(4-Fluorophenyl)-1H-pyrazolo[3 ,4-c ]pyridine-4-carboxylic acid (2-cyano-pyridin-4-ylmethyl)-amide; 1-(4-Fluorophenyl)-6-oxy-1H-pyrazolo[3,4-c]pyridine-4-carboxylic acid 3-trifluoromethyl-benzylamide and 1-(4-Fluorophenyl)-6-methyl-4-(3-trifluoromethyl-benzylcarbamoyl)-1H-pyrazolo[3,4-c ]pyridin-6-ium; iodide. The compounds are useful in treating chronic inflammation, allergies, contact dermatitis, psoriasis, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, inflammatory bowel disease, Guillain-Barre syndrome, Cohn's disease, ulcerative colitis, graft versus host disease, Alzheimer's disease, asthma, chronic kidney disease, sepsis, autoimmune myocarditis and systemic lupus erythematosus. Also disclosed is a pharmaceutical composition comprising a compound of formula (I), the use of a compound of formula (I) in the manufacture of a medicament and the process for preparing or synthesising a compound of formula (I).
Patent NZ-595794-A (NZ)
Title: A hydraulic mooring cable holding device
Inventor: ZEGELAAR WILLEM CORNELIS
IPC: B63B21/00
Filed: 2010-03-29
Abstract: 595794 Disclosed is a mooring cable holding device for holding one end of a cable moored to a ship. The device comprises a hydraulic cylinder (22), with a piston (20) in the hydraulic cylinder, and a reservoir (24), with hydraulic liquid and gas, forming an operationally closed hydraulic circuit. A first directional valve (25) is provided between a first side of the piston and the reservoir to selectively allow flow of the hydraulic liquid from the reservoir to the hydraulic cylinder. A second directional valve (26) is provided between a first side of the piston and the reservoir to selectively allow flow of the hydraulic liquid from the hydraulic cylinder to the reservoir. The first and second directional valve being set to open at a first and second pressure difference from the hydraulic cylinder to the reservoir respectively, whereby the second pressure difference exceeds the first pressure difference by a predetermined threshold. This is such that the device provides slack on the mooring cable when the force on the cable exceeds a force threshold and, when the force decreases, allows liquid from the reservoir to push back the piston, to haul in the mooring cable.
Patent NZ-596500-A (NZ)
Title: Pneumococcal polysaccharide conjugate vaccine
Inventor: BIEMANS RALPH LEON
IPC: A61K39/09
Filed: 2006-12-20
Abstract: 596500 Provided is a Streptococcus pneumoniae immunogenic composition comprising 10 or more capsular saccharides from different S. pneumoniae serotypes which are conjugated to a carrier protein, and comprising 3 or more different carrier proteins, wherein the composition comprises: serotype 19F capsular saccharide conjugated to diphtheria toxoid (DT); serotype 18C capsular saccharide conjugated to tetanus toxoid (TT); serotype 1, 4, 5, 6B, 7F, 9V, 14 and 23F capsular saccharides conjugated to protein D from Haemophilus influenzae.
Patent NZ-597873-A (NZ)
Title: Process for lignin conversion to chemicals or fuels with h2 generated from lignin depolymerization products
Inventor: CHEN JOHN Q
IPC: B01J23/40
Filed: 2010-10-06
Abstract: Disclosed is a process for the production of hydrocarbons and hydrogen from lignin, comprising: combining lignin with water and an acidic or basic catalyst to form an intermediate stream comprising lignin-D and light oxygenates; decomposing the light oxygenates with a decomposition catalyst to form a second intermediate stream comprising hydrogen, wherein the decomposition catalyst comprises a mixture of metals on a support, wherein the metals are selected from chromium, gold, zinc, copper, platinum, silver, palladium, rhodium, rhenium, osmium, ruthenium, iridium and mixtures thereof, and the support is selected from the group consisting of inorganic oxides, zeolites, molecular sieves, carbon, silica, silica-alumina, boron nitride, silica nitride, and mixtures thereof; and combining the second intermediate stream with a hydrogenation catalyst to form a third stream comprising hydrogenated or partially hydrogenated compounds, wherein the hydrogenation catalyst comprises a noble metal on a support, wherein the noble metal is selected from the group consisting of platinum (Pt), palladium (Pd), and mixtures thereof, and wherein the catalyst support is selected from the group consisting of zeolites, molecular sieves, Ah03, Si02, MgO, Zr02, Ti02, mixed metal oxides, carbon, and mixtures thereof..
Patent NZ-601039-A (NZ)
Title: A brick panel and method of forming a brick panel
Inventor: INGLIS CATHERINE MARY
IPC: E04C1/39
Filed: 2011-01-14
Abstract: 601039 A unitary brick panel includes a plurality of bricks, each having a front and a rear, top and bottom and sides. The bricks are arranged in a grid-like pattern in a plurality of courses and are embedded in a body of cementitious material. The depth to which each brick is embedded is such that the front of each brick either protrudes from the cementitious material or is flush with that material. A plurality of reinforcing bars extends vertically from the panel when erected, and those bars extend through recesses 17 formed in the bricks. Each recess opens through the rear of the brick. The recesses 17 are otherwise substantially filled with the cementitious material
Patent NZ-601642-A (NZ)
Title: Method and apparatus for dry-conveying material for dry gunning application
Inventor: STENDERA JAMES W
IPC: B05B7/14
Filed: 2011-03-16
Abstract: 601642 A method and apparatus for conveying dry material for a gunning application make use of a rotary air lock in communication with a material source and an inductor. The material is supplied through the rotary air lock to the inductor under a pressure greater than the outlet pressure of the inductor.
Patent NZ-601851-A (NZ)
Title: A composition for preparing ceramic fiber and a biosoluble ceramic fiber prepared therefrom for heat insulating material at high temperature
Inventor: SEOG IN SIG
IPC: C04B35/22
Filed: 2010-12-14
Abstract: The present disclosure relates to a composition for preparing ceramic fiber and a biosoluble ceramic fiber prepared therefrom for heat insulating material at high temperature, more specifically, a composition for preparing ceramic fiber comprising SiO2 (silica, silicon dioxide) as a network-forming oxide, CaO (calcium oxide) and MgO (magnesium oxide) as modifier oxides, and ZrO2 (zirconium dioxide), Al2O3 (aluminium oxide) and B2O3 (boron trioxide) as intermediate oxides with appropriate ratios, which improves the solubility of the ceramic fiber in artificial body fluid; shows good thermal/mechanical properties such as heat resistance, high-temperature viscosity, compressive strength and restoration when used at a high temperature of 1260 ℃; and provides an economic effect that a ceramic fiber can be prepared easily by using the existing facilities, and a biosoluble ceramic fiber prepared therefrom for heat insulating material at high temperature.
Patent NZ-605813-A (NZ)
Title: Trolley for transporting loads
Inventor: PAUL JAMES KUKULIES
IPC: B62B7/02
Filed: 2011-07-07
Abstract: A trolley 10 for manual transport of loads includes one or two wheels 12 supported and rotating on an axle 14, a pair of handles 20, 22 which extend upwardly when the trolley is in an upright, non-travel position, a load carrying frame 30 extending forward from the handles, and a pair of spaced support legs 50, 52 extending down from the load carrying frame and positioned either side of the one or two wheels. The support legs are adapted to support the load carrying frame substantially parallel to a support surface, such as the ground, when the trolley is in the upright, non-travel position. As alternatives: the trolley includes one wheel, two wheels mounted between the handles, can be interchanged between having one wheel or two wheels, or can be interchanged between having two wheels in which the wheels are mounted either side of the handles proximal to the support legs and having two wheels in which the wheels are mounted between the handles.
Patent NZ-610227-A (NZ)
Title: Dredging assembly
Inventor: GRUNDLEHNER GERRIT JAN
IPC: E02F9/06
Filed: 2011-10-06
Abstract: Disclosed is a dredging assembly (1) for reclaiming sand or minerals from a seafloor (9) or for excavating a trench in the seabed (9). The dredging assembly comprises an elongated vessel (2), a submersible part (4) and hoisting mechanisms (26, 27, 28, 29). The hosting mechanisms are placed on the vessel (2) for suspending a number of hoist cables (10, 11, 12, 13). The hoist cables are connected to the submersible part for lowering it into the water alongside the vessel. The submersible part is provided with an elongated pump part (5) and an elongated suction part (6). The forward end of the suction part is connected to the rear end of the pump part, and the reward end of the suction part is provided with a suction nozzle (62). When in the submerged condition the submersible part rests on the seafloor (9), and the dredging assembly is provided with a flexible pipe (8) connecting the vessel and the pump part to each other for pumping reclaimed sand or minerals upwards there through. The submersible part (4) is configured to angle downward and rearward so that as the vessel is propelled forwards the suction nozzle (62) may be dragged along the seabed (9). The hoisting mechanisms may be arranged so the submersible part lies directly below the vessel during dredging. Also disclose is a method of dredging using the assembly.
Patent NZ-616428-A (NZ)
Title: A pet door assembly
IPC: E06B7/32
Filed: 2013-10-09
Abstract: A pet door assembly 10 for mounting in a structural panel 18, comprises a closure assembly having a frame assembly 11 that defines a passageway suitable for passage of an animal, the frame assembly 11 being configured to be partially received in an opening 16 in the structural panel 18 and including an abutment member 24 capable of being brought into abutment with a surface of the structural panel 18 peripheral to the opening 16, a closure member 44 mounted in the frame assembly 11 to be displaceable by an animal between open and closed positions to open and close the opening 16, respectively, to accommodate the passage of the animal through the opening 16, and a retainer 64 that is configured also to be partially received in the opening 16 in the structural panel 18, and including an abutment member capable of being brought into abutment with an opposite surface of the structural panel 18.The frame assembly 11 and the retainer 64 include a circumferentially arranged interlocking arrangement that is configured so that the frame assembly 11 and the retainer 64 can be urged into locking engagement with each other to sandwich the surfaces of the structural panel 18, peripheral to the opening 16, between the abutment members. The interlocking arrangement is further configured so that the frame assembly 11 and the retainer 64 can disengage from each other when the frame assembly 11 and the retainer 64 are rotated relative to each other.
Patent NZ-625824-A (NZ)
Title: A head track for a wall
Inventor: AGUSTIN ALBERTO GOMEZ
IPC: E04C3/07
Filed: 2014-06-03
Abstract: A wall assembly (10) including a first wall (11) that is secured to a second wall (12). Each of the walls (11, 12) has a head track (13). The head track (13) has a base provided with a plurality of apertures (21). At least one of the apertures (21), adjacent an end portion of the head track (13) is a slot having its major direction of extension transverse relative to the longitudinal axis of the head track (13). The slot allows for movement of the head track once it is fastened to a structure by fasteners (23), particularly in the case of an extreme event.
Patent NZ-630165-A (NZ)
Title: Quantification of non-reducing end glycan residual compounds
Inventor: CRAWFORD BRETT E
IPC: G01N33/68
Filed: 2013-09-26
Abstract: A method of determining in an individual the presence, identity and/or severity of a disease or condition associated with abnormal glycan biosynthesis, degradation, or accumulation comprises (a) generating a first biomarker comprising a glycan residual compound and generating a second biomarker comprising a glycan residual compound; (c) using an analytical instrument to detect the presence of and/or measure the amount of the first and second biomarker produced and displaying or recording the presence of or a measure of a population of the first and second biomarkers, and (d) monitoring and/or comparing the amounts of the first and second biomarkers in a biological sample. The presence of and/or measure of the amounts of the first and second biomarkers are utilized to determine the presence, identity, and/or severity of the disease or condition. The first biomarker is generated by treating a population of glycans, in or isolated from a biological sample from the individual, with at least one digesting glycan enzyme and prior to the enzyme treatment, the first biomarker is not present in abundance in samples from individuals with the disease or condition relative to individuals without the disease or condition. The first biomarker is a non-reducing end glycan residual compound. The second biomarker is generated by treating a population of glycans, in or isolated from a biological sample from the individual, with at least one digesting glycan enzyme in the same or different digestion step as provided in step (a) and prior to the enzyme treatment, the second biomarker is not present in abundance in samples from individuals with the disease or condition relative to individuals without the disease or condition, and provided that 1) the second biomarker is a non-reducing end glycan residual compound different from the first biomarker, 2) the second biomarker is a reducing end glycan residual compound, 3) the second biomarker is an internal glycan residual compound, or 4) when the disease or condition is caused by an abnormal function of a glycan degradation enzyme in the individual, the second biomarker is a biomarker generated by treating the first biomarker with the glycan degradation enzyme that is functioning abnormally in the individual.
Patent NZ-630345-A (NZ)
Title: Animal feed composition containing encapsulated glucono delta-lactone
Inventor: MAAS JOHANNES ANTONIUS MARIA
IPC: A23L33/00
Filed: 2013-03-08
Abstract: The disclosure relates to an animal feed composition comprising 0.05-8.0 wt.% of encapsulated GDL. The encapsulation may be by a lipophilic matrix containing 50-100 wt.% of one or more lipophilic components selected from triglycerides, diglcyerides, monoglycerides, esters of monoglycerides, esters of diglycerides, phospholipids, fatty acid esters of sugars and waxes. The animal feed may be calf milk replacer or sow milk replacer.
Patent NZ-631065-A (NZ)
Title: Apparatus and methods for sealing a vascular puncture
Inventor: HUNDERTMARK RONALD
IPC: A61M37/00
Filed: 2013-03-19
Abstract: An apparatus for sealing a puncture through a vessel wall 1506 comprising a positioning assembly 1512 including an expandable member 1514 disposed at a distal portion of the positioning assembly 1512, the expandable member 1514 configured to move between an unexpanded state and an expanded state; a support member, the positioning assembly 1512 configured to move axially within the support member; and a handle comprising an outer housing portion and an inner housing portion, the inner housing portion connected to the support member, the outer housing portion configured to selectively engage the inner housing portion. The handle comprises a first actuator and a second actuator, the first and second actuators at least partially exposed to the outside of the outer housing portion to permit manipulation by a user. The first actuator is an expandable member retraction actuator configured to at least partially retract the expandable member proximally relative to the support member. The second actuator is selected from the group consisting of: a support member actuator configured to move the support member distally relative to the outer housing portion; and a locking actuator configured to prevent relative movement between the inner housing portion and the outer housing portion until the locking actuator is activated to disengage the inner housing portion..
Patent NZ-631169-A (NZ)
Title: Method and apparatus for controlling pressurized gas delivered to a patient
Inventor: MARTIN DION CHARLES CHEWE
IPC: A61M16/20
Filed: 2014-03-14
Abstract: A CPAP or sleep apnoea breathing apparatus is described. The apparatus controls the volume of air or gas inhaled by the user by blocking the outflow when the user breathes in and opening it when they breathe out. The apparatus (3000) includes a nasal mask or plenum chamber (3118) an inspiratory or inhalation tube, limb or conduit (3104), an expiratory or outflow conduit (3106) and a valve, vent or aperture for releasing the gas (3108). The gas is inhaled from a cross-flow stream, i.e. it flows past the nose and the user inhales from the stream. The mask creates a seal around the user’s nose. The apparatus also includes an exchanger or condenser for recovering or recycling heat or moisture from the plenum chamber.
Patent NZ-741335-A (NZ)
Title: New bicyclic dihydroisoquinoline-1-one derivatives
Inventor: MOHR PETER
IPC: C07D491/113
Filed: 2012-11-27
Abstract: Provided are dihydroisoquinoline-1-one derivative compounds of formula (I), wherein the variables are as defined in the specification. Examples of the compounds include 6-Chloro-2-pyridin-3-yl-3,4-dihydro-2H-isoquinolin-1-one and 5-Chloro-3,3-dimethyl-2-[5-(1-methyl-1H-pyrazol-4-ylmethyl)-pyridin-3-yl]-2,3-dihydro-isoindol-1-one. The compounds are inhibitors of aldosterone synthase. The compounds may be useful in the treatment of chronic kidney disease, congestive heart failure, hypertension, primary aldosteronism and Cushing syndrome.
Patent NZ-743971-A (NZ)
Title: Antibodies to tau
Inventor: HOLTZMAN DAVID
IPC: G01N33/53
Filed: 2013-07-03
Abstract: This invention relates to antibodies to tau and methods of use thereof, particularly to isolated monoclonal antibodies specifically binding tau and capable of reducing tau aggregation.
Patent NZ-749522-A (NZ)
Title: Process of cutting and assembling diamonds to form composite diamond having enhanced brilliance and shade
Inventor: KAKADIYA MAHESHBHAI SHAMBHUBHAI
IPC: A44C27/00
Filed: 2016-10-03
Abstract: The present invention is a novel technique for setting a multiplicity of diamonds into a setting to enhance their beauty and presentation. The technique is worked on stones that have been assorted, blocked, mapped and includes the steps of sawing, polishing, assembling and grooving of white, naturally couloured and treated colour natural diamonds. The present invention provides method where each diamonds is separately processed for ultimate brilliance and cumulative refraction. The flat surfaces of the adjacent diamond are joined to form the complete design. The assembled diamonds are arranged by grooving and providing support to form final pattern of the jewelry. The present process is advantageous with regards to usage of maximum utilization of raw diamond and process that gives the brilliance of a large diamond and expensive appearance to the user.
Patent NZ-756382-A (NZ)
Title: Plated steel
Inventor: MITSUNOBU TAKUYA
IPC: B32B15/20
Filed: 2018-01-26
Abstract: Provided is a plated steel which curbs LME and the formation of blowholes, and which improves the corrosion resistance of welding heat-affected zones. This plated steel is hot-dipped plated steel comprising steel and a plating layer which includes a Zn-Al-Mg alloy layer which is positioned on the surface of the steel. In a cross section of the Zn-Al-Mg alloy layer, the surface area percentage of MgZn2phase is 45-75%, the total surface area percentage of MgZn2phase and Al phase is at least 70%, and the surface area percentage of the Zn-Al-MgZn2ternary eutectic structure is 0-5%. The plating layer has a predetermined chemical composition.